CEPHALEXIN ANHYDROUS

SynDRA canonical compound SYN0019336 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Mechanism of action	bacterial cell wall synthesis inhibitor
Indication	bone and joint infections \| genitourinary tract infections \| otitis \| respiratory tract infections \| skin infections
Disease area	infectious disease \| otolaryngology

All known targets

SLC15A2
dacA
dacB
dacC
ftsI
mrcA
mrcB
mrdA
pbpC

Mechanisms of action (all sources)

bacterial cell wall synthesis inhibitor
mrcA INHIBITOR
mrcB INHIBITOR
dacC INHIBITOR
mrdA INHIBITOR
ftsI INHIBITOR
dacA INHIBITOR
dacB INHIBITOR

Drug classes

Cephalosporin Antibacterial
Anti-Bacterial Agents
Anti-Infective Agents

ATC classes

J01D · OTHER BETA-LACTAM ANTIBACTERIALS

Cross-references

PubChem CID: 27447
ChEMBL: CHEMBL1727
DrugBank: DB00567
ChEBI: CHEBI:3534
KEGG: D00263
RxNorm: 1299782
Wikipedia: Cefalexin
TTD: D0Z5EM
LINCS BRD: BRD-K90733503

Synonyms

Reported adverse events

Eosinophilia
Nausea
Hypersensitivity
Stevens-Johnson syndrome
Seizure
Dyspepsia

Look up CEPHALEXIN ANHYDROUS in the interactive SynDRA portal →